Press
Release

Taste masking acetaminophen chewable tablets using maltitol plus intense sweetener synergy

8th European Paediatric Formulation Initiative (EuPFI) Conference, in partnership with International Association for Pharmaceutical Technology, will take place in Lisbon (Portugal) on 20th of September 2016.

EuPFI is a consortium working in a pre-competitive way on paediatric drug formulations. Members are from academia, hospital pharmacies, pharmaceutical industry (Innovators, Generics, Contract Research Organizations (CRO) and Excipient Manufacturers) with European Medicine Agency (EMA) as an observer. It aims to expedite the development of better and safer medicines for children by identifying and scoping issues and challenges in paediatric formulation development. It brings together the voluntary, academic, pharmaceutical industry, hospitals and regulatory agency in order to tackle the development of age appropriate formulation for paediatrics. It provides funding, expertise and resources to support the solutions to the problems and new technologies emerging from academic research.

This event is the opportunity for our ROQUETTE PHARMA team to present the following scientific poster:

Taste masking acetaminophen chewable tablets using maltitol plus intense sweetener synergy

Interest to combine a common intense sweetener (sucralose) and a common bulk sweetener SweetPearl® (maltitol) to mask the bitterness in APIs.

Our experts from ROQUETTE PHARMA team will welcome you during this conference and will be at your disposal to answer any of your questions about our enabling technologies and services adapted to all patient population including paediatrics.

Meet us à EuPFI!